Response Genetics is focused on the development and sale of molecular diagnostic testing services for cancer. The company’s technologies enable extraction and analysis of genetic information derived from tumor cells stored as formalin-fixed and paraffin-embedded specimens. RGDX’s principal customers include oncologists and pathologists. In addition to diagnostic testing services, the company sells its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. For more information, visit the company’s Web site: http://www.responsegenetics.com

Let us hear your thoughts below: